{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:51:10Z","timestamp":1790628670557,"version":"4.1.0"},"reference-count":4,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Red blood cell (RBC) alloimmunization can occur because of exposure to various sensitizing factors and poses a constant threat in transfusion. Assisted reproductive technology (ART) involves manipulation of sperm, ova, or embryos\n                    <jats:italic>in vitro<\/jats:italic>\n                    with the goal of producing a pregnancy. We present an interesting case of ART-induced maternal alloimmunization (AIMA) due to anti-c in a woman carrying a twin pregnancy. A 35-year-old primigravida, whose blood sample typed as group B, D+ and showed anti-c in her plasma, delivered twins by cesarean section. The spouse\u2019s blood group was also B, D+. The blood groups of twins I and II were confirmed to be B, D+ and AB, D+, respectively. The RBCs of twin I were c+, but those of twin II and the spouse were c\u2212. On enquiry, history of ART with donor sperm insemination was noted. Because there were no previous sensitizations, antigenic inheritance from the sperm donor to twin I could be the possible sensitizing factor for maternal alloimmunization. To the best of our knowledge, this case is the first report of ART-induced maternal RBC alloimmunization in the literature. History of ART exposures should be documented, and appropriate RBC phenotyping of the parent as well as potential ART donors will help in timely detection or prevention of hemolytic disease of the fetus and newborn or other AIMA-related complications.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2024-020","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:22:26Z","timestamp":1735654946000},"page":"149-152","source":"Crossref","is-referenced-by-count":1,"title":["A case of assisted reproductive technology\u2013induced maternal alloimmunization: an emerging sensitizing factor to consider?"],"prefix":"10.2478","volume":"40","author":[{"given":"Deepti","family":"Sachan","sequence":"first","affiliation":[{"name":"Transfusion Medicine, Dr . Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research , Chennai , Tamilnadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varnisha","family":"Thiyagarajan","sequence":"additional","affiliation":[{"name":"Transfusion Medicine, Dr . Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research , Chennai , Tamilnadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi Krishna","family":"G","sequence":"additional","affiliation":[{"name":"Transfusion Medicine, Dr . Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research , Chennai , Tamilnadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"2026082308010161562_j_immunohematology-2024-020_ref_001","doi-asserted-by":"crossref","unstructured":"Zalpuri S, Zwaginga JJ, van der Bom JG. Risk factors for alloimmunisation after red blood cell transfusions (R-FACT): a case cohort study. BMJ 2012;2:e001150. doi: 10.1136\/bmjopen-2012-001150.","DOI":"10.1136\/bmjopen-2012-001150"},{"key":"2026082308010161562_j_immunohematology-2024-020_ref_002","doi-asserted-by":"crossref","unstructured":"Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA 2021;326:65\u201376. doi: 10.1001\/jama.2021.4788.","DOI":"10.1001\/jama.2021.4788"},{"key":"2026082308010161562_j_immunohematology-2024-020_ref_003","unstructured":"Jain M, Singh M. Assisted reproductive technology (ART) techniques [article online]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2024. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576409. Accessed 11 October 2024."},{"key":"2026082308010161562_j_immunohematology-2024-020_ref_004","unstructured":"Royal College of Obstetricians & Gynaecologists. The management of women with red cell antibodies during pregnancy (green-top guideline no. 65). Available from https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/the-management-of-women-with-red-cell-antibodies-during-pregnancy-green-top-guideline-no-65\/. Accessed 22 August 2024."}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2024-020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T08:01:41Z","timestamp":1787472101000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2024-020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":4,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]},"published-print":{"date-parts":[[2024,12,1]]}},"alternative-id":["10.2478\/immunohematology-2024-020"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2024-020","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}